Helicobacter pylori factors involved in the development of gastroduodenal mucosal damage and ulceration

Journal of Clinical Gastroenterology

Volumn 25, Issue SUPPL. 1, 1997, Pages

  Figura, Natale ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

cagA; Chronic gastritis; H. pylori infection; Peptic ulcer; Urease; vacA

Indexed keywords

ALCOHOL DEHYDROGENASE; ALPHA LEVO FUCOSIDASE; AMMONIUM DERIVATIVE; BACTERIAL ENZYME; CATALASE; HEMOLYSIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOLIPASE; PROTEINASE; SIALIDASE; SUPEROXIDE DISMUTASE; UREA;

BACTERIAL VIRULENCE; CELL PROLIFERATION; CONFERENCE PAPER; GASTRODUODENAL ULCER; GENE STRUCTURE; HELICOBACTER PYLORI; LIPID PEROXIDATION; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; STOMACH INJURY; STRAIN DIFFERENCE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL TOXINS; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; PEPTIC ULCER;

EID: 0031413426     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199700001-00025     Document Type: Conference Paper

References (134)

1. On SLW. Identification methods for campylobacters, helicobacters and related organisms. Clin Microbiol Rev 1996;9: 405-22.
2. Handt LK, Fox JG, Stalis IH, et al. Characterization of feline Helicobacter pylori strains and associated gastritis in a colony of domestic cats. J Clin Microbiol 1995;33:2280-9.
3. Crabtree JE. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 1996;10(suppl 1):29-37.
4. Blaser MJ. Gastric campylobacter-like organisms, gastritis and peptic ulcer disease. Gastroenterology 1987;93:371-83.
5. Graham D. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989;96:615-25.
6. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric adenocarcinoma. N Engl J Med 1991;325:1127-31.
7. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330: 1267-71.
8. Xiang Z, Censini S, Bayeli PF, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that the clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating toxin. Infect Immun 1995; 63:94-8.
9. Phadnis SH, Parlow MH, Levy M, et al. Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect Immun 1996;64: 905-12.
10. Dunn BE, Phadnis SH, Vakil NB, Schneider BH. Localization of urease in H. pylori in human gastric biopsies [Abstract]. Gastroenterology 1996;110(suppl):A99.
11. Marshall BJ, Barrett LT, Prakesh C, McCallum RW, Guerrant RL. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology 1990; 99:697-702.
12. Eaton KA, Brooks CL, Morgan DR, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1992;59: 2470-5.
13. Williams C, Preston T. Slater C, Hossack M, McColl KEL. H. pylori uses urea for amino acid synthesis at neutral pH [Abstract]. Gut 1995;37(suppl 1):A62.
14. Harris PR, Mobley HLT, Pérez-Pérez GI, Blaser MJ, Smith PD. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 1996;111:419-25.
15. Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting pH. Am J Gastroenterol 1987;82:192-9.
16. Mobley HLT, Hu L-T, Foxall PA. Helicobacter pylori urease: properties and role in pathogenesis. Scand J Gastroenterol 1991;(suppl 187):39-46.
17. Dekigai H, Murakami M, Kita T. Mechanism of Helicobacter pylori-associated gastric mucosa injury. Dig Dis Sci 1995;40: 1332-9.
18. Katsuaki K, Sasano H, Ohara S, et al. DNA damages caused by ammonia administration in rat stomach [Abstract]. Gastroenterology 1996;110(suppl):A150.
19. Collins CM, Dorazio SEF. Bacterial ureases: structure, regulation of expression and role in pathogenesis. Mol Microbiol 1993;9:907-13.
20. Hazell SL, Lee A. Campylobacter pylori, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet 1986;2:15-7.
21. + moving through gastric mucus. Scand J Gastroenterol 1989;24:761-8.
22. Xu J-K, Goodwin CS, Cooper M, Robinson J. Intracellular vacuolation caused by the urease of Helicobacter pylori. J Infect Dis 1990;161:1302-4.
23. Smoot DT, Mobley HTL, Chippendale GR, Lewison JF, Resau JH. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun 1990;58:1992-4.
24. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth culture filtrates of Campylobacter pylori. J Med Microbiol 1988;26:93-9.
25. Telford JL, Ghiara P, Dell'Orco M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994;179:1653-8.
26. Cover TL, Vaughn SG, Cao P, Blaser MJ. Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. J Infect Dis 1992;166:1073-8.
27. Triebling AT, Korsten MA, Dlugosz JW, Paronetto F, Lieber CS. Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia. Dig Dis Sci 1991;36: 1089-96.
28. Segal ED, Shon J, Tompkins LS. Characterization of Helicobacter pylori urease mutants. Infect Immun 1992;60: 1883-9.
29. Matsui T, Matsukawa Y, Sakai T, Nakamura K, Aoike A, Kawai K. Effect of ammonia on cell-cycle progression of human gastric cancer cells. Eur J Gastroenterol Hepatol 1995;7(suppl 1):S79-81.
30. Ito S, Kohli Y, Kato T, et al. Differences in urease activity in Helicobacter pylori cultured from patients with gastroduodenal diseases. Eur J Gastroenterol Hepatol 1995;7(suppl 1): S83-8.
31. Figura N. Progress in defining the inflammatory cascade. Eur J Gastroenterol Hepatol 1995;7:296-302.
32. Thomas EL, Grisham MB, Jefferson M. Myeloperoxidase-dependent effect on amines on functions of isolated neutrophils. J Clin Invest 1983;72:441-54.
33. Murakami M, Yoo JK, Teramura S, Yamamoto K, Saita H, Kita T. Protective effect of taurine against ammonia-induced gastric mucosal lesions in rats. Jpn J Pharmacol 1989;51:569-71.
34. Mai UHE, Pérez-Pérez G, Allen JB, Wahl SM, Blaser MJ, Smith PD. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 1992;175:517-25.
35. Ghiara P, Marchetti M, Blaser MJ, et al. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of diseases. Infect Immun 1995;63:4154-60.
36. 2 activity: a factor in peptic ulceration? J Clin Pathol 1992;45:221-4.
37. Ottlecz A, Romero JJ, Hazell SL, Graham DY, Lichtenberger LM. Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Dig Dis Sci 1993;38:2971-80.
38. Wetkamp JH, Pérez-Pérez GI, Bode G, Malfertheiner P, Blaser MJ. Identification and characterisation of Helicobacter pylori phospholipase activity. Int J Med Microbiol 1993; 280:11-27.
39. Munch F, Bode G, Ditschumeit H, Malfertheiner P. Demonstration of a phospholipid-rich zone in human gastric epithelium which is damaged by Helicobacter pylori. Gastroenterology 1993;105:1698-704.
40. 2 activity in human gastric juice. Scand J Gastroenterol 1992;27:1011-7.
41. Meyers DJ, Berk RS. Characterisation of phospholipase C from Pseudomonas aeruginosa as a potent inflammatory agent. Infect Immun 1990;58:659-66.
42. Goggin PM, Marrero JM, Spychal RT, Jackson PA, Corbishley CM, Northfield TC. Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection - effect of clearance and eradication. Gastroenterology 1992;103:1486-90.
43. Koyama T, Tadano J, Kawasaki S, et al. Effect of Helicobacter pylori infection on phospholipids of gastric mucosa in patients with peptic ulcer [Abstract]. Gastroenterology 1996; 110(suppl):A162.
44. Nilius M, Malfertheiner P. Contact angle measurement. In: Lee A. Mégraud F, eds. Helicobacter pylori: techniques for clinical diagnosis & basic research. 1st ed. London: WB Saunders, 1996:286-98.
45. Smith AW, Chanhal B, French GL. The human gastric pathogen Helicobacter pylori has a gene encoding an enzyme first classified as a mucinase in Vibrio cholerae. Mol. Microbiol 1994;13:153-60.
46. Wadstrom T, Hirmo S, Boren T. Biochemical aspects of Helicobacter pylori colonization of the human gastric mucosa. Aliment Pharmacol Ther 1996;10(suppl 1):17-27.
47. Baxter A, Campbell CJ, Cox DM, Grinham SJ, Pendelebury JE. Proteolytic activities of human Campylobacter pylori and ferret gastric campylobacter-like organisms. Biochem Biophys Res Commun 1989;163:1-7.
48. Slomiany BL, Bilski J, Sarosiek J, et al. Campylobacter pylori degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun 1987;144:307-14.
49. Markesich DC, Anand BS, Lew GM, Graham DY. Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel. Gut 1995;36:327-9.
50. Piotrowski J, Majka J, Skrodzka D, Slomiany A, Slomiany BL. Susceptibility of growth factors to degradation by H. pylori protease: effect of ebrotidine [Abstract]. Gastroenterology 1996;110(suppl):A992.
51. Taha AS, Curry GW, Morton R, Park RHR, Beattie AD. Gastric mucosal hepatocyte growth factor in Helicobacter pylori gastritis and peptic ulcer disease. Am J Gastroenterol 1996;91:1407-9.
52. Lynch DAF, Mapstone NP, Clarke AMT, et al. Cell proliferation in Helicobacter pylori-associated gastritis and the effect of eradication therapy. Gut 1995;36:346-50.
53. Fujiwara Y, Wyle F, Arakawa T, Kobayashi K, Tarnawski A. H.P. toxin reduces EGF binding to its receptor and proliferative response of human gastric Kato III cells to EGF stimulation. Important mechanism for H.P. interference with the ulcer healing? [Abstract]. Gastroenterology 1995;108: A97.
54. Romano M, Ricci V, Zarrilli R, et al. Helicobacter pylori and gastric mucosa healing: an in vitro study on the role of VacA and CagA [Abstract]. Ital J Gastroenterol 1995;27(suppl 1): 221.
55. Figura N, Guglielmetti P, Rossolini A, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcer and from patients with chronic gastritis only. J Clin Microbiol 1989;27:225-6.
56. Micots I, Augeron C, Laboisse CL, Muzeau F, Mégraud F. Mucin exocytosis: a major target for Helicobacter pylori. J Clin Pathol 1993;46:241-5.
57. Beil W, Wagner S, Enss M, Sewing K-F. A lipid extract of Helicobacter pylori broth inhibits mucin synthesis and secretion in the gastric mucous cell line HM02 [Abstract]. Gastroenterology 1009;110(suppl):A63.
58. Papini E, Bugnoli M, De Bernard M, et al. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolation of HeLa cells. Mol Microbiol 1993;7:323-7.
59. Dwarakanath AD, Tsai HH, Sunderland D, et al. The production of neuraminidase and fucosidase by Helicobacter pylori: their possible relationship to pathogenicity. FEMS Immunol Med Microbiol 1995;12:213-6.
60. Roine RP, Samela KS, Höök-Nikanee J, Kosunen TU, Salspuro MP. Alcohol dehydrogenase mediated production by Helicobacter pylori - a possible mechanism behind gastric injury. Life Sci 1992;51:133-7.
61. Salaspuro M. H. pylori alcohol dehydrogenase. In: Hunt RH, Tytgat GHJ, eds. Helicobacter pylori, basic mechanisms to clinical cure. Dordrecht: Kluwer Academic, 1994:232-42.
62. Kenny WC. Acetaldehyde adducts of phospholipids. Alcohol Clin Exp Res 1982;6:412-6.
63. Gaines KC, Salhany JM, Tuma DJ, Sporrel MF. Reaction of acetaldehyde with human erythrocyte membrane proteins. FEBS Lett 1977;75:115-9.
64. Stevens VJ, Fanti WJ, Newman CB, Rims RV, Cerami A, Peterson CM. Acetaldehyde adducts with hemoglobin. J Clin Invest 1981;67:361-9.
65. Roine RP, Sllanoukee P, Itälä L, et al. Binding of acetaldehyde to rat gastric mucosa. Scand J Gastroenterol 1993;28 (suppl 197):72-5.
66. Matysiak-Budnik T, Kärkkäinen P, Methuen T, Roine RP, Salaspuro M. Inhibition of gastric cell proliferation by acetaldehyde. J Pathol 1995;177:317-22.
67. Nilius M, Malfertheiner P. Helicobacter pylori enzymes. Aliment Pharmacol Ther 1996;10(suppl 1):65-71.
68. Moutiala A, Helender IM, Pyhala L, Kosunen TU, Moran AP. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun 1992;60:1714-6.
69. Birkholz S, Knipp U, Nietzke C, Adamek RJ, Operkuch W. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear cells in comparison to lipopolysaccharide of other intestinal bacteria. FEMS Immunol Med Microbiol 1993;6:317-24.
70. Moran AP. The role of lipopolysaccharide in Helicobacter pylori pathogenesis. Aliment Pharmacol Ther 1996;10(suppl 1):39-50.
71. Valkonen KH, Wadström T, Moran AP. Interaction of lipopolysaccharide of Helicobacter pylori with basement membrane protein laminin. Infect Immun 1994;62:3340-8.
72. Slomiany BL, Piotrowski J, Sengupta S, Slomiany A. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun 1991;175:963-70.
73. Slomiany BL, Liaub YH, Lopez RA, Piotrowski J, Czajkowski A, Slomiany A. Effect of Helicobacter pylori on the synthesis of sulfated gastric mucin. Biochem Int 1992;27:687-97.
74. Young GO, Stemmet N, Lastovica A, et al. Helicobacter pylori lipopolysaccharide stimulates gastric mucosal pepsinogen secretion. Aliment Pharmacol Ther 1992;6:169-77.
75. Miu K, Kidd M, Sandor A, Tang LH, Blaser MJ. H. pylori lipopolysaccharide (LPS) stimulates DNA synthesis and histamine release in purified rat enterochromaffin-Iike (ECL) cells [Abstract]. Gastroenterology 1996;110(suppl):A199.
76. Figura N, Bugnoli M, Cusi MG, et al. Pathogenic mechanisms of Helicobacter pylori: production of cytotoxin. In: Malfertheiner P, Ditschuneit H, eds. Helicobacter pylori, gastritis and peptic ulcer. Berlin, Heidelberg: Springer-Verlag, 1990:86-95.
77. Fox JG, Dewhirst FE, Tully JG, et al. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 1994;32:1238-45.
78. Taylor NS, Fox JG, Yan L. In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species. J Med Microbiol 1995;42:48-52.
79. Figura N. Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection. Aliment Pharmacol Ther 1996;10(suppl 1):79-96.
80. Cover TL, Cao P, Murthy UK, Sipple MS, Blaser MJ. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest 1992;90:913-8.
81. Goossens H, Glupczynski Y, Burette A, Lambert J-P, Vlaes L, Butzler J-P. Role of the vacuolating toxin from Helicobacter pylori in the pathogenesis of duodenal and gastric ulcer. Med Microbiol Lett 1992;1:153-9.
82. Rautelin H, Blomberg B, Fredlund H, Järnerot G, Danielsson D. Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease. Gut 1993; 34:599-603.
83. Phadnis SH, Ilver D, Janzon L, Normark S, Westblom TU. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 1994;62:1557-65.
84. Tee W, Labmert JR, Pegorer M, Dwyer B. Cytotoxin production by Helicobacter pylori more common in peptic ulcer disease. J Clin Microbiol 1995;33:1203-5.
85. Papini E, Gottardi E, Satin B, et al. The vacuolar ATPase proton pump is present on intracellular vacuoles induced by Helicobacter pylori. J Med Microbiol 1996;45:84-9.
86. +-ATPase of gastric cells. A target of Helicobacter pylori cytotoxic activity. FEBS Lett 1993;334:158-60.
87. Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujiki N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int J Cancer 1994;54:56-80.
88. Lehn N, Hatz R, Schutze S, et al. Phospholipase-C and phospholipase-A2 in H. pylori from patients with gastric cancer, MALT lymphoma or gastritis [Abstract]. Am J Gastroenterol 1994;89:1394.
89. Fox JG, Correa P, Taylor NS, et al. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 1992;87:1554-60.
90. Cover TL, Tummuru MKR, Cao P, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994; 269:10566-73.
91. Atherton JC, Coa P, Peek RM Jr, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 1995;270:17771-7.
92. Manetti R, Massari P, Burroni D, et al. The Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies. Infect Immun 1995;63: 4476-80.
93. Lupetti P, Heuser JE, Manetti R, et al. Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J Cell Biol 1996;133:801-7.
94. Kodama R, Fujioka T, Kimoto M, Gotho T, Takahashi K, Nasu M. The virulent difference of H. pylori in gastric mucosa [Abstract]. Gastroenterology 1996;110(suppl):A939.
95. Melchers K, Weitzenegger T, Buhmann A, Steinhilber W, Sachs G, Schafer KP. Cloning and membrane topology of a P-type ATPase from Helicobacter pylori. J Biol Chem 1996; 27:446-57.
96. De Bernard M, Papini E, De Filippis V, et al. Low pH activates the vacuolating toxin of Helicobacter pylori which becomes acid and pepsin resistant. J Biol Chem 1995;76: 23937-40.
97. - Helicobacter pylori (Hp) supernatants on the bioactivity of basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) in vitro [Abstract]. Gastroenterology 1996;110(suppl):A249.
98. Correa P, Ruiz B, Shi T-Y, et al. Helicobacter pylori and nucleolar organizer regions in the gastric antral mucosa. Am J Clin Pathol 1994;101:656-60.
99. Bechi P, Balzi M, Becciolini A, et al. Helicobacter pylori and cell proliferation of the gastric mucosa: possible implication for gastric carcinogenesis. Am J Gastroenterol 1996;91:271-6.
100. De Koster E, Lage A, Buset M, et al. Influence of HP vacuolating toxin on gastric antrum and corpus mucosal cell proliferation status. Acta Gastroenterol Belg 1993;68(suppl):63.
101. Cahill RJC, Sant S, Beattie S, Hamilton H, O'Morain C. Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer. Eur J Gastroenterol Hepatol 1994;6:1123-7.
102. Beales I, Crabtree JE, Covacci A, Calam J. Antibodies to CagA protein in patients with H. pylori infection and atrophic gastritis [Abstract]. Gut 1995;37(suppl 1):A37.
103. Wagner S, Beil W, Nietert M, et al. Antiproliferative effect of Helicobacter pylori on human gastric epithelial cells in vitro [Abstract]. Gastroenterology 1996;110(suppl):A1040.
104. Mekasha GC, Vernon K, Allen CR, Smoot DT. H. pylori inhibits growth of gastric cells in vitro [Abstract]. Gastroenterology 1996;110(suppl):A193.
105. Watanabe S, Hirose M, Wang XE, Ohkura R, Murai T, Sato N. Direct inhibition of gastric epithelial restoration by Helicobacter pylori water extracts in vitro [Abstract]. Gastroenterology 1996;110(suppl):A292.
106. Ricci V, Ciacci C, Sommi P, et al. Helicobacter pylori inhibits gastric mucosal cell migration and proliferation in vitro [Abstract]. Gastroenterology 1996;110(suppl):A240.
107. Brännström J, Zachrisson K, Engstrand L, Uribe A. Helicobacter pylori stimulates DNA synthesis in a small intestinal cell line [Abstract]. Gastroenterology 1996;110(suppl):A871.
108. Konturek PC, Ernst H, Bobrzynski A, et al. Salivary and gastric epidermal growth factor (EGF) and gastric mucosal EGF expression in duodenal ulcer (DU) patients before and after eradication of Helicobacter pylori [Abstract]. Gastroenterology 1996;110(suppl):A161.
109. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994;107:3569-77.
110. Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996;38:498-501.
111. Naito Y, Yoshikawa T, Yagi N, et al. Cell growth inhibition and apoptosis induced by monochloramine in a gastric mucosal cell line [Abstract]. Gastroenterology 1996;110(suppl): A205.
112. Jones NL, Yeger H, Cutz E, Sherman PM. Helicobacter pylori apoptosis of gastric antral epithelial cells in vivo [Abstract]. Gastroenterology 1996;110(suppl):A933.
113. Behar S, Van Houten N, Bamford K, Reyes VE, Crowe SE, Ernst PB. H. pylori induces apoptosis in gastric epithelial cells which is enhanced by cytokines derived from Th1 cells [Abstract]. Gastroenterology 1996;110(suppl):A862.
114. + strains dissociates gastric epithelial proliferation from apoptosis [Abstract]. Gastroenterology 1996;110(suppl): A575.
115. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128 kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90:5791-5.
116. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993;61:1799-809.
117. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxic activity. Infect Immun 1990;58:603-10.
118. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332-5.
119. Crabtree JE, Wyatt JI, Sobala GM, et al. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993;34:1339-43.
120. Oderda G, Figura N, Bayeli PF, et al. Serologic IgG recognition of Helicobacter pylori cytotoxin-associated protein, peptic ulcer and gastroduodenal pathology in childhood. Eur J Gastroenterol Hepatol 1993;5:695-9.
121. Housson M-O, Gottrand F, Vachee A, et al. Importance in diagnosis of gastritis of detection by PCR of the cagA gene in Helicobacter pylori strains isolated from children. J Clin Microbiol 1995;33:3300-3.
122. + Helicobacter pylori strains. J Clin Microbiol 1995;33:1496-500.
123. Crabtree JE, Farmery SM, Lindley IJD, Figura N, Peichl P, Tompkins DS. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994;47:945-50.
124. Crabtree JE, Xiang Z, Lindley IJD, Tompkins DS, Rappuoli R, Covacci A. Induction of interleukin-8 secretion from gastric epithelial cells by cagA. Negative isogenic mutant of Helicobacter pylori. J Clin Pathol 1962;48:967-9.
125. Miehlke S, Kibler K, Kim JG, et al. Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol 1996;91: 1322-5.
126. Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes Type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA (in press).
127. Tummuru MKR, Sharma SA, Blaser MJ. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol 1995;18:867-76.
128. Peek RM, Thompson SA, Atherton JC, Blaser MJ, Miller GG. Expression of a novel ulcer-associated H. pylori gene, iceA, following adherence to gastric epithelial cells [Abstract]. Gastroenterology 1996;110(suppl):A225.
129. Evans DJ, Evans DG, Lambert HC, Nakono H. Identification of four new prokaryotic bacterioferritins from Helicobacter pylori, Anabaena variabilis, Bacillus subtilis and Treponema pallidum, by analysis of gene sequences. Gene 1995;153:123-7.
130. Yoshida N, Granger DN, Evans DJ, et al. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 1993;105:1431-40.
131. Zhang QB, Nakshabendi IM, Mokhashi MS, et al. Cytotoxin production and neutrophil activation by Helicobacter pylori in patients with peptic ulceration and chronic gastritis [Abstract]. Gastroenterology 1996;110(suppl):A306.
132. Kawata H, Ito A, Kodama K, Honda S, Fujioka T, Nasu M. Association between napA genotypes of Helicobacter pylori and severity of gastritis [Abstract]. Gastroenterology 1996; 110(suppl):A152.
133. Owen RJ, Desai M, Figura N, et al. Comparison between degree of histological gastritis and DNA fingerprints, cytotoxicity and adhesivity of Helicobacter pylori from different gastric sites. Eur J Epidemiol 1993;9:315-21.
134. Pretolani S, Figura N, Miglio F, et al. The San Marino H. pylori study-II: a population-based study on the prevalence of endoscopie lesions and its association with H. pylori and anticytotoxin-protein (CagA) antibodies [Abstract]. Am J Gastroenterol 89;1307:1994.